Stephen Carey, the Senior Vice President and Chief Financial Officer of Ani Pharmaceuticals, has executed a stock sale amounting to $264,960. This transaction reflects Carey’s decision to divest a portion of his holdings in the company. The details of the sale, including the number of shares sold and the specific date of the transaction, have been disclosed in accordance with regulatory requirements.
Related Articles
Don't miss out on breaking stories and in-depth articles.